(2) Now Has 78 Patents Issued, Filed, Licensed or in Preparation As Taeus® Commercial Launch Plans Advance ANN ARBOR, MI / ACCESSWIRE / January 13, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ®), has recently been issued United States Patent 10888898 (the '898 patent) entitled "Shielded Ultrasound Transducer and Imaging System Employing the Same" from the United States Patent and Trademark Office. This is the 13 th U.S. patent issued to ENDRA for its TAEUS ® technology. "ENDRA's goal is to develop applications for our proprietary TAEUS ® technology in areas of high unmet clinical need and for which there are no practical existing tools. The recently issued '898 patent provides more robust intellectual property (IP) protection for our TAEUS